Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Patent
1998-05-18
2000-08-15
Henley, III, Raymond
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
A61K 31495
Patent
active
061037222
ABSTRACT:
Methods and pharmaceutical compositions of matter are disclosed and claimed relating to cardioprotective effect mediated by delta (.delta.) opioid receptor agonists or more specifically delta-1 (.delta..sub.1)-opioid receptor agonists. Further, methods drawn to reducing ischemic damage to organs and tissues having delta (.delta.) opioid receptor agonists or more specifically delta-1 (.delta..sub.1)-opioid receptors are disclosed and claimed. Specifically, methods and pharmaceutical compositions of matter are taught as a means of providing cardioprotective treatment through the administration of delta (.delta.) opioid receptor agonists or more specifically delta-1 (.delta..sub.1)-opioid receptor agonists, such as TAN67(-). Said methods and pharmaceutical compositions are envisioned as a means of reducing myocardial infarction arising from the onset and sequelae of myocardial ischemia.
REFERENCES:
Chien et al--J. Mol. Cell. Cardiol 28(9), 1895-1990 (Abstract), 1906.
Schultz et al--Am J. Physiol. 268 (5(AART 4), 1995.
Kobari et al--J. Cereb. Blood FLow Metab., 5(1), 34-9 (Abstract), 1985.
May et al, Adv. Biosoi (Oxford), 25, 531-4 (Abstract), 1985.
Wong et al, J. Mol. Cell. Cardiol. 22(10) 112-75, 1990.
Calderon et al., "Probes for Narcotic Receptor Mediated Phenomena. 19.sup.1 Synthesis of (+)-4-[(.alpha.R)-.alpha.-((2S,5R)-4-Allyl-2,5-dimethyl-1-piperazinyl)-3-m ethoxybenzyl]-N,N-diethylbenzamide (SNC 80): A Highly Selective, Nonpeptide .delta. Opioid Receptor Agonist", J. Med. Chem., 37:2125-2128 (1994).
Dondio et al., "Discovery of a Novel Class of Substituted Pyrrolooctahydroisoquinolines as Potent and Selective .delta. Opiod Agonists, Based on an Extension of the Message--Address Concept", J. Med. Chem., 40:3192-3198 (1997).
Negus and Picker, "BW373U86: A Non-Peptidic, Systematically-Active .delta. Opioid Agonist", CNS Drug Reviews, 2(1):52-74 (1996).
Portughese et al., "A Selective .delta..sub.1 Opiod Receptor Agonist Derived from Oxymorphone. Evidence for Separate Recognition Sites for .delta..sub.1 Opioid Receptor Agonists and Antagonists", J. Med. Chem., 36:2572-2574 (1993).
Jimenez, I. et al., Farmacol. Clin. Exp. (1988) 5(2):265 XP-002079022.
International Search Report for International Application No. PCT/JP98/03288 (1998).
Gross Garrett
Schultz Jo El
Henley III Raymond
The Medical College of Wisconsin Research Foundation Inc.
LandOfFree
Ischemic preconditioning does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Ischemic preconditioning, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Ischemic preconditioning will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2007073